A BILL 
To amend title XVIII of the Social Security Act to ensure 
that hospitals receive adequate payment for the acquisi-
tion of hematopoietic stem cells under the Medicare pro-
gram, and for other purposes. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘Patient Access to Cel-
4
lular Transplant Act’’ or the ‘‘PACT Act’’. 
5
21:42 May 09, 2019
H2498
2 
•HR 2498 IH
SEC. 2. HEMATOPOIETIC STEM CELL ACQUISITION PAY-
1
MENTS. 
2
Section 1886 of the Social Security Act (42 U.S.C. 
3
1395ww) is amended— 
4
(1) in subsection (a)(4), in the second sentence, 
5
by inserting ‘‘for cost reporting periods beginning on 
6
or after October 1, 2020, costs related to hematopoi-
7
etic stem cell acquisition for the purpose of an allo-
8
geneic hematopoietic stem cell transplant (as de-
9
scribed in subsection (d)(5)(M)),’’ after ‘‘October 1, 
10
1987),’’; 
11
(2) in subsection (d)— 
12
(A) in paragraph (4)(C)(iii)— 
13
(i) by inserting ‘‘or payments under 
14
paragraph (5)(M) (beginning with fiscal 
15
year 2021)’’ after ‘‘fiscal year 1991)’’; and 
16
(ii) by inserting ‘‘or payments under 
17
paragraph (5)(M)’’ before the period at the 
18
end; and 
19
(B) in paragraph (5), by adding at the end 
20
the following new subparagraph: 
21
‘‘(M)(i) For cost reporting periods beginning on or 
22
after October 1, 2020, in the case of a subsection (d) hos-
23
pital that furnishes an allogeneic hematopoietic stem cell 
24
transplant to an individual during such a period, payment 
25
to such hospital for hematopoietic stem cell acquisition 
26
21:42 May 09, 2019
H2498
3 
•HR 2498 IH
shall be made on a reasonable cost basis. The items in-
1
cluded in such hematopoietic stem cell acquisition shall be 
2
specified by the Secretary through rulemaking. 
3
‘‘(ii) For purposes of this subparagraph, the term 
4
‘allogeneic hematopoietic stem cell transplant’ means, with 
5
respect to an individual, the intravenous infusion of 
6
hematopoietic cells derived from bone marrow, peripheral 
7
blood stem cells, or cord blood, but not including embry-
8
onic stem cells, of a donor to an individual that are or 
9
may be used to restore hematopoietic function in such in-
10
dividual having an inherited or acquired deficiency or de-
11
fect.’’. 
12
Æ 
21:42 May 09, 2019
H2498
